Clinical trials
Terminated Pneumonia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
91 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 3 |
| 2004 | 3 |
| 2005 | 4 |
| 2006 | 4 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 5 |
| 2016 | 6 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 27 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 91 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 5 |
| AstraZeneca | 3 |
| Sanofi | 3 |
| Massachusetts General Hospital | 2 |
| Polyphor Ltd. | 2 |
| University Health Network, Toronto | 2 |
| University Hospital, Bordeaux | 2 |
| Abbott Nutrition | 1 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Anbics Management-Services Ag | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pneumonia | 91 |
| COVID-19 | 27 |
| Respiratory Distress Syndrome | 10 |
| Respiratory Tract Infections | 9 |
| Community-Acquired Pneumonia | 7 |
| Coronavirus Infections | 7 |
| Lung Diseases | 6 |
| Respiratory Insufficiency | 6 |
| Acute Lung Injury | 5 |
| Pneumonia, Ventilator-Associated | 5 |
Trials
Showing 1 to 25 of 91. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.